3D - Screen SM
killing and immune cell activation
With 1000s of experimental cancer drugs in too many clinical trials there are not enough patients to test them on.
Nilogen has a solution.
With 3D-ScreenSM you can evaluate 100s of drugs and drug combinations for tumor cell killing and immune cell activation in fresh patient 3D tumoroids to identify the most effective drugs and combinations before moving on to clinical trial.
Eliminate early stage failures and de-risk your drug development to save time and valuable resources.
LEARN MORE FROM US
Read more about the services
that Nilogen has to offer